58 results
8-K
EX-99.1
KA
Kineta Inc
31 Mar 23
Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
of public health epidemics affecting countries or regions in which Kineta has operations or does business, such as the COVID-19 pandemic; the timing
8-K
EX-99.2
98nh4evi6v6jiqazwund
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
t63 asyssp9qpsui
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.6
iqh5vskciflz8c0co4bj
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.1
ueqn3xmp
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
sinp09hxszlcl2fv
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
mbddb7
10 Nov 22
Prospectus supplement
4:21pm
425
zkj8s14ep0ee0i5 cq
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.2
yh4g2 mkwegvnwau3r5
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm